πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

39 results for β€œRani” Clear

  1. RT-102 (80 ΞΌg)

    Rani Therapeutics Holdings

    Healthy Volunteers

    phase 1 other completed

    1 trial

  2. RT-114 is the RaniPill capsule with PG-102 for the treatment of obesity

    Rani Therapeutics Holdings

    Obesity

    phase 1 other active

    1 trial

  3. RaniPill capsule containing octreotide

    Rani Therapeutics Holdings

    Healthy Volunteers

    phase 1 other completed

    1 trial

  4. Repetitive Transcranial Magnetic Stimulation

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Use

    phase 1 other terminated

    1 trial

  5. Stelara

    Rani Therapeutics Holdings

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  6. Tranilast

    First Tracks Biotherapeutics

    Mucinoses

    phase 1 small molecule active

    1 trial

  7. Chinese Herb Huang-Chi-Wu-Wu-Tang

    China SXT Pharmaceuticals

    Intracranial Arterial Stenosis

    approved small molecule active

    1 trial

  8. Lixiana 30 mg film-coated tablets, Lixiana 60 mg film-coated tablets

    Institut fΓΌr biomedizinische Analytik NMR-Imaging GmbH

    High risk atrial fibrillation patients with previous intracranial hemorrhage

    approved small molecule active

    1 trial

  9. Methylprednisolone (Injectable Form)

    INTEGRATED BIOPHARMA INC

    Unruptured Intracranial Aneurysms

    approved small molecule active

    1 trial

  10. Recaticimab and Statin

    First Tracks Biotherapeutics

    Intracranial Atherosclerosis

    approved small molecule active

    1 trial

  11. intravenous tranexamic acid (TXA) infusion

    First Tracks Biotherapeutics

    Spontaneous Intracranial Hemorrhage

    approved small molecule active

    1 trial

  12. Adjustment of Antiplatelet Drugs

    First Tracks Biotherapeutics

    Intracranial Aneurysm

    small molecule completed

    1 trial

  13. PCSK9 inhibitor

    First Tracks Biotherapeutics

    Intracranial Artery Stenosis

    small molecule active

    1 trial

  14. Ticagrelor monotherapy

    First Tracks Biotherapeutics

    Intracranial Aneurysm

    small molecule active

    1 trial

  15. repetitive transcranial magnetic stimulation (rTMS)

    BRIGHT MINDS BIOSCIENCES INC.

    Amphetamine Addiction

    other completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources